HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Guest Access | Sign In via User Name/Password

This Article Full Text Free Full Text (PDF) Free Submit a response View responses Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Article Archive Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (48) Citing Articles via Google Scholar Google Scholar Articles by Dresler, C. M. Search for Related Content PubMed PubMed Citation Articles by Dresler, C. M.

Phase III Intergroup Study of Talc Poudrage vs Talc Slurry Sclerosis for Malignant Pleural Effusion^*

^* From the Tobacco Unit (Dr. Dresler), International Agency for Research on Cancer, Lyon, France; Lutheran General Hospital (Dr. Olak), Cancer Care Center, Park Ridge, IL; Cancer Center Biostatics (Dr. Herndon), Durham, NC; Brigham and Women’s Hospital (Drs. Richards and Sugarbaker), Boston, MA; Radiology Department (Dr. Scalzetti), SUNY Upstate Medical University (Dr. Kohman), Syracuse, NY; Cancer Supportive Services (Dr. Fleishman), Continuum Cancer Centers of New York: Beth Israel & St. Luke’s-Roosevelt, New York, NY; Department of Surgery (Dr. Kernstine), University of Iowa, Iowa City, IA; Thoracic Surgery (Dr. Demmy), Roswell Cancer Institute, Buffalo, NY; Department of Surgery (Dr. Jablons), Mount Zion Medical Center, University of California, San Francisco, San Francisco, CA; Department of Surgery (Dr. Daniel), Department of Surgery, University of Virginia Health System, Charlottesville, VA; and Medical College of Wisconsin (Dr. Haasler), Milwaukee, WI.

Correspondence to: Carolyn Dresler, MD, MPA, Head, Tobacco Unit, International Agency for Research on Cancer, Lyon, France; e-mail: Carolyn_dresler{at}ksg03.harvard.edu

Study objective: To demonstrate the efficacy, safety, and appropriate mode of instillation of talc for sclerosis in treatment of malignant pleural effusions (MPEs).

Design: A prospective, randomized trial was designed to compare thoracoscopy with talc insufflation (TTI) to thoracostomy and talc slurry (TS) for patients with documented MPE.

Measurements: The primary end point was 30-day freedom from radiographic MPE recurrence among surviving patients whose lungs initially re-expanded > 90%. Morbidity, mortality, and quality of life were also assessed.

Results: Of 501 patients registered, those eligible were randomized to TTI (n = 242) or TS (n = 240). Patient demographics and primary malignancies were similar between study arms. Overall, there was no difference between study arms in the percentage of patients with successful 30-day outcomes (TTI, 78%; TS, 71%). However, the subgroup of patients with primary lung or breast cancer had higher success with TTI than with TS (82% vs 67%). Common morbidity included fever, dyspnea, and pain. Treatment-related mortality occurred in nine TTI patients and seven TS patients. Respiratory complications were more common following TTI than TS (14% vs 6%). Respiratory failure was observed in 4% of TS patients and 8% of TTI patients, accounting for five toxic deaths and six toxic deaths, respectively. Quality-of-life measurement demonstrated less fatigue with TTI than TS. Patient ratings of comfort and safety were also higher for TTI, but there were no differences on perceived value or convenience of the procedures.

Conclusions: Both methods of talc delivery are similar in efficacy; TTI may be better for patients with either a lung or breast primary. The etiology and incidence of respiratory complications from talc need further exploration.

Key Words: insufflation • malignant pleural effusion • slurry • talc

This article has been cited by other articles:

				C. A. Jimenez, A. D. Mhatre, C. H. Martinez, G. A. Eapen, A. Onn, and R. C. Morice Use of an Indwelling Pleural Catheter for the Management of Recurrent Chylothorax in Patients With Cancer Chest, November 1, 2007; 132(5): 1584 - 1590. [Abstract] [Full Text] [PDF]

				A. R. Haas, D. H. Sterman, and A. I. Musani Malignant Pleural Effusions: Management Options With Consideration of Coding, Billing, and a Decision Approach Chest, September 1, 2007; 132(3): 1036 - 1041. [Abstract] [Full Text] [PDF]

				J. P. van Meerbeeck and A. Bottomley In Reply J. Clin. Oncol., October 1, 2006; 24(28): 4667a - 4668. [Full Text] [PDF]

				T. Laisaar, V. Palmiste, T. Vooder, and T. Umbleja Life expectancy of patients with malignant pleural effusion treated with video-assisted thoracoscopic talc pleurodesis Interactive CardioVascular and Thoracic Surgery, June 1, 2006; 5(3): 307 - 310. [Abstract] [Full Text] [PDF]

				L. J. Kohman Cancer and leukemia group B surgery committee. Clin. Cancer Res., June 1, 2006; 12(11): 3622s - 3627s. [Abstract] [Full Text] [PDF]

				C. Tan, A. Sedrakyan, J. Browne, S. Swift, and T. Treasure The evidence on the effectiveness of management for malignant pleural effusion: a systematic review. Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 829 - 838. [Abstract] [Full Text] [PDF]

				A. Tremblay and G. Michaud Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. Chest, February 1, 2006; 129(2): 362 - 368. [Abstract] [Full Text] [PDF]

				O. Dikensoy, Z. Zhu, E. Donnelly, G. T. Stathopoulos, K. B. Lane, and R. W. Light Combination Therapy With Intrapleural Doxycycline and Talc in Reduced Doses Is Effective in Producing Pleurodesis in Rabbits Chest, November 1, 2005; 128(5): 3735 - 3742. [Abstract] [Full Text] [PDF]

eLetters: